Northwestern Mutual Wealth Management
RGC icon

Northwestern Mutual Wealth Management’s Regencell Bioscience RGC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.65K Hold
301
– – ﹤0.01% 3164
2025
Q4 		$6.32K Buy
+301
New +$4.89K ﹤0.01% 3145

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Northwestern Mutual Wealth Management's RGC Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Regencell Bioscience (RGC) position steady in Q1 2026 at 301 shares worth $7.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

Northwestern Mutual Wealth Management first reported a position in RGC in Q4 2025 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

  • Northwestern Mutual Wealth Management held 301 shares of Regencell Bioscience worth $7.65K as of Q1 2026.
  • Northwestern Mutual Wealth Management left its Regencell Bioscience share count unchanged in Q1 2026.
  • Regencell Bioscience made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3164 holding.
  • Northwestern Mutual Wealth Management first reported a position in Regencell Bioscience in Q4 2025 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.